2015
DOI: 10.1016/j.carres.2014.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Re-visiting the structure of heparin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
86
0
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 118 publications
(89 citation statements)
references
References 124 publications
0
86
0
3
Order By: Relevance
“…acid (either D-glucuronic acid (GlcA) or L-iduronic acid (IdoA)) and D-glucosamine (either D-glucosamine N-acetylate (GlcNAc) or Dglucosamine N-sulfate (GlcNSO 3 )) and bear O-sulfate substituents in various positions [16], preferentially in position 2 of IdoA and in position 6 of GlcNSO 3 . The anticoagulant activity is mainly due to the high affinity binding to antithrombin (AT) through a specific and rare pentasaccharide sequence that has a central GlcNSO 3 sulfated at 3-O, flanked by an unsulfated GlcA and by a 2-O sulfated iduronic acid [17].…”
Section: Introductionmentioning
confidence: 99%
“…acid (either D-glucuronic acid (GlcA) or L-iduronic acid (IdoA)) and D-glucosamine (either D-glucosamine N-acetylate (GlcNAc) or Dglucosamine N-sulfate (GlcNSO 3 )) and bear O-sulfate substituents in various positions [16], preferentially in position 2 of IdoA and in position 6 of GlcNSO 3 . The anticoagulant activity is mainly due to the high affinity binding to antithrombin (AT) through a specific and rare pentasaccharide sequence that has a central GlcNSO 3 sulfated at 3-O, flanked by an unsulfated GlcA and by a 2-O sulfated iduronic acid [17].…”
Section: Introductionmentioning
confidence: 99%
“…Whilst much is now known about the nature of commercially prepared pharmaceutical heparin, both in its unfractionated and low-molecular weight forms, with respect to structure, biological activity and clinical effects (2)(3)(4), the physiological role of endogenous heparin is considerably less well understood. It has long been known, however, that heparin possesses additional effects that are both separate to, and separable from, its well-characterized effects on blood coagulation, many of which involve modulation of aspects of immune or inflammatory cell function (5,6).…”
Section: Introductionmentioning
confidence: 99%
“…The early reports of the beneficial effects of heparin in inflammation were attributed to the heparin binding and inhibition of chemokines, complement, growth and angiogenic factors, as reviewed recently [1,5,6,7]. Heparin can also bind to adhesion mediators expressed during inflammation, such as selectins, integrins and their receptors [8,9].…”
Section: Anti-inflammatory Cardiovascular and Tissue Protection Actimentioning
confidence: 99%
“…Heparin and LMWHs are widely used for the prevention and treatment of thrombotic events by inhibiting antithrombin III (AT) and factor Xa through a specific oligosaccharide binding sequence (ATBR) present in only one third of unfractionated heparin chains as has been well-documented in two recent reviews [1,2]. Heparin, the most negatively charged biopolymer has an average of four negative charges for each disaccharide unit, can interact with a wide range of proteins, with interactions that exhibit a range of specificities [3] and induce several associated biological activities.…”
Section: Introductionmentioning
confidence: 99%